Patients / advocates

AI can flag hidden cardiac risk. The dangerous part is what health systems do next

Metabolic syndrome may leave a signature in mitochondrial DNA. The biomarker race should not outrun the evidence

Breast Cancer Gets a New PI3K Pathway Option.

Bladder Cancer Surgery Just Became a System Test

Down Syndrome Cannot Stay Outside Alzheimer’s Trials

Cataplexy Is Waiting on an FDA Clock

More Children Got A First Vaccine. Millions Still Fell Out Of The System.

AstraZeneca’s heart drug failure raises a brutal question: how much treatment is too much treatment?

Beans for men, broccoli for women? The real cardiometabolic warning is that risk starts by 22
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
